Skip to main content
OpenTrials
Completed

NCT Number: NCT05815355

Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease

Patients with Crohn's disease (CD) could develop complications such as stricture, intestinal fistula and abdominal abscess. Some CD patients had poor response to medical therapy. The efficacy of exclusive enteral nutrition (EEN) to these adult active CD patients is still unclear. The investigators aim to study the efficacy of EEN in induction of remission in adult active CD patients with complications or poor response to drugs.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

About this study

Active CD patients following up in our center who had been diagnosed as complicated disease with stricture, intestinal fistula, abdominal abscess and no response to drugs, were recruited since July 2013. Patients were only offered EEN for 12 weeks without using other drugs except that patients with abscess could use antibiotic therapy with or without percutaneous drainage. The disease activity was assessed by the Crohn's disease activity index (CDAI). CDAI<150 was taken as achieving clinical remission. Demographics and clinical variables were recorded. Nutritional (body mass index, albumin) and inflammatory (High sensitivity C-reactive protein and platelet) index were evaluated at baseline, week 4 and week 12. Some patients performed colonoscopy and/or computed tomography enterography (CTE) /resonance enterography(MRE) before and after EEN. Mucosal healing was assessed under endoscopy with SES-CD and the size of abscess was detected by CTE /MRE.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • >18 years old
  • Patients with CD was diagnosed clinically according to previously established international criteria [9]
  • The diagnosis of stricture, fistula and abdominal abscess was confirmed by ultrasound, CT enterography (CTE), and endoscopy. The bowel stricture should mainly cause by inflammation. Intolerance or failure to steroids or IFX was judged by medical history
  • The disease was in an active period.

Exclusion criteria

  • Intolerant to EEN or need emergency surgery
  • The bowel stricture should mainly cause by fibrosis

Treatment and study plan

exclusive enteral nutrition treatment group

Dietary Supplement

Primary outcomes

  1. Clinical remission after 12 weeks EEN

    Time frame: July 2013 to October 2015

    The Crohn's disease activity index (CDAI)<150 was taken as achieving clinical remission.

  2. Mucosal healing after EEN

    Time frame: July 2013 to October 2015

    Mucosal healing was assessed under endoscopy with SES-CD.

Secondary outcomes

  1. The high sensitivity C-reactive protein (mg/L) -Inflammatory parameter assessment

    Time frame: baseline, week 4 and week 12

    The high sensitivity C-reactive protein (mg/L) was evaluated at baseline, week 4 and week 12.

  2. Inflammatory parameter assessment

    Time frame: baseline, week 4 and week 12

    The platelet (10*9/L) was evaluated at baseline, week 4 and week 12.

  3. The body mass nutritional parameter assessment

    Time frame: baseline, week 4 and week 12

    The body mass was evaluated at baseline, week 4 and week 12.

  4. The albumin (g/L)- nutritional parameter assessment

    Time frame: baseline, week 4 and week 12

    The albumin (g/L) was evaluated at baseline, week 4 and week 12.

Sponsors and collaborators

Lead sponsor

Sixth Affiliated Hospital, Sun Yat-sen University

Other

Registry information

Official study title

Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease With Complications or Failure of Medical Treatment

Important dates

Study start
2013
Primary completion
2015
Study completion
2015
First posted
Apr 18, 2023
Registry last updated
Apr 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.